New medications
For the companies developing projects in the following fields:
- targeted medications
- Biopharmaceuticals - monoclonal antibodies and its derivatives, medications based on autologous or allogeneic cells
Jury
Vadim Balabanyan
Lomonosov Moscow State University
Kira Blong
AstraZeneca
Polina Denisenko
Publika
Nadezhda Kartashova
the State Institute of Drugs and Good Practices (SID&GP)
Nadezhda Kartashova
the State Institute of Drugs and Good Practices (SID&GP)
Dmitry Kulish
Skoltech
Nataliya Mushenkova
Pharmstd Ventures
Dmitrii Ovchinnikov
SELECTA RUS
Elizaveta Rozhdestvenskaya
Primer Capital
Marina Sekacheva
Sechenov University
Arseniy Shabashvili
Freelance
Igor Tsvetkov
S-GROUP Corporate Communication Center
Kirill Volynchik
RVC InfraFund